Search research articles
Contact Us
Filters
Showing results (121-130 of 379) with videos related to
Page
of 38
Sort By:
Haematologica
|
November 11, 2003
Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia
Marinella Veltroni, Lucia De Zen, Maria Colomba Sanzari, et al.
Biochemical Pharmacology
|
August 14, 2010
Hypoxia and succinate antagonize 2-deoxyglucose effects on glioblastoma
Francesca Pistollato, Sara Abbadi, Elena Rampazzo, et al.
Bone Marrow Transplantation
|
January 17, 2018
Haploidentical stem cell transplantation cures autoimmune hepatitis and cerebrovascular disease in a patient with sickle cell disease
Elisabetta Calore, Antonio Marzollo, Mara Cananzi, et al.
Plos One
|
June 10, 2016
Cognition and the Default Mode Network in Children with Sickle Cell Disease: A Resting State Functional MRI Study
Raffaella Colombatti, Marta Lucchetta, Maria Montanaro, et al.
Nature Communications
|
October 6, 2018
Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies
Francesco Roncato, Fatlum Rruga, Elena Porcù, et al.
Blood
|
August 23, 2005
Independent clones at separable stages of differentiation, bearing different GATA1 mutations, in the same TMD patient with Down syndrome
Jürgen Groet, Claire Mulligan, Monica Spinelli, et al.
Haematologica
|
April 16, 2013
What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia?
Chiara Palmi, Maria Grazia Valsecchi, Giulia Longinotti, et al.
Oncotarget
|
October 16, 2013
DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia
Riccardo Masetti, Marco Togni, Annalisa Astolfi, et al.
Vascular Pharmacology
|
May 29, 2016
Vascular disrupting activity of combretastatin analogues
Elena Porcù, Alessia Salvador, Irina Primac, et al.
Journal of Medicinal Chemistry
|
March 28, 2008
Isoindolo[2,1-a]quinoxaline derivatives, novel potent antitumor agents with dual inhibition of tubulin polymerization and topoisomerase I
Patrizia Diana, Annamaria Martorana, Paola Barraja, et al.
Page
of 38
Search research articles
Search
Showing results (121-130 of 379) with videos related to
Sort By:
Page
of 38
Haematologica
|
November 11, 2003
Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia
Marinella Veltroni, Lucia De Zen, Maria Colomba Sanzari, et al.
Biochemical Pharmacology
|
August 14, 2010
Hypoxia and succinate antagonize 2-deoxyglucose effects on glioblastoma
Francesca Pistollato, Sara Abbadi, Elena Rampazzo, et al.
Bone Marrow Transplantation
|
January 17, 2018
Haploidentical stem cell transplantation cures autoimmune hepatitis and cerebrovascular disease in a patient with sickle cell disease
Elisabetta Calore, Antonio Marzollo, Mara Cananzi, et al.
Plos One
|
June 10, 2016
Cognition and the Default Mode Network in Children with Sickle Cell Disease: A Resting State Functional MRI Study
Raffaella Colombatti, Marta Lucchetta, Maria Montanaro, et al.
Nature Communications
|
October 6, 2018
Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies
Francesco Roncato, Fatlum Rruga, Elena Porcù, et al.
Blood
|
August 23, 2005
Independent clones at separable stages of differentiation, bearing different GATA1 mutations, in the same TMD patient with Down syndrome
Jürgen Groet, Claire Mulligan, Monica Spinelli, et al.
Haematologica
|
April 16, 2013
What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia?
Chiara Palmi, Maria Grazia Valsecchi, Giulia Longinotti, et al.
Oncotarget
|
October 16, 2013
DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia
Riccardo Masetti, Marco Togni, Annalisa Astolfi, et al.
Vascular Pharmacology
|
May 29, 2016
Vascular disrupting activity of combretastatin analogues
Elena Porcù, Alessia Salvador, Irina Primac, et al.
Journal of Medicinal Chemistry
|
March 28, 2008
Isoindolo[2,1-a]quinoxaline derivatives, novel potent antitumor agents with dual inhibition of tubulin polymerization and topoisomerase I
Patrizia Diana, Annamaria Martorana, Paola Barraja, et al.
Page
of 38